Education
About Us
Working with TipRanks
Follow Us
New Horizon Health Limited (HK:6606)
:6606
Total Valuation
New Horizon Health Limited has a market cap or net worth of HK$6.47B. The enterprise value is ―.
Market CapHK$6.47B
Enterprise Value―
Share Statistics
New Horizon Health Limited has 448,754,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding448,754,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
New Horizon Health Limited’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -2.31%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-2.31%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee734.83K
Profits Per Employee-76.12K
Employee Count1,041
Asset Turnover0.30
Inventory Turnover1.68
Valuation Ratios
The current PE Ratio of New Horizon Health Limited is ―. New Horizon Health Limited’s PEG ratio is 0.84.
PE Ratio―
PS Ratio8.47
PB Ratio3.05
Price to Fair Value3.05
Price to FCF-13.90
Price to Operating Cash Flow-13.08
PEG Ratio0.84
Income Statement
In the last 12 months, New Horizon Health Limited had revenue of 764.96M and earned -79.24M in profits. Earnings per share was -0.19.
Revenue764.96M
Gross Profit646.17M
Operating Income-159.61M
Pretax Income-79.66M
Net Income-79.24M
EBITDA-45.97M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was -521.08M and capital expenditures -103.65M, giving a free cash flow of -624.73M billion.
Operating Cash Flow-521.08M
Free Cash Flow-624.73M
Free Cash Flow per Share-1.39
Dividends & Yields
New Horizon Health Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.91
52-Week Price Change0.00%
50-Day Moving Average14.14
200-Day Moving Average14.14
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
New Horizon Health Limited upcoming earnings date is Mar 16, 2026, TBA (Confirmed).
Last Earnings DateAug 15, 2025
Next Earnings DateMar 16, 2026
Ex-Dividend Date―
Financial Position
New Horizon Health Limited as a current ratio of 8.80, with Debt / Equity ratio of 11.55%
Current Ratio8.80
Quick Ratio8.49
Debt to Market Cap0.03
Net Debt to EBITDA19.28
Interest Coverage Ratio-7.37
Taxes
In the past 12 months, New Horizon Health Limited has paid 655.00K in taxes.
Income Tax655.00K
Effective Tax Rate>-0.01
Enterprise Valuation
New Horizon Health Limited EV to EBITDA ratio is -121.70, with an EV/FCF ratio of -12.00.
EV to Sales7.31
EV to EBITDA-121.70
EV to Free Cash Flow-12.00
EV to Operating Cash Flow-13.56
Balance Sheet
New Horizon Health Limited has HK$1.68B in cash and marketable securities with HK$448.00M in debt, giving a net cash position of HK$1.23B billion.
Cash & Marketable SecuritiesHK$1.68B
Total DebtHK$448.00M
Net CashHK$1.23B
Net Cash Per ShareHK$2.74
Tangible Book Value Per ShareHK$5.03
Margins
Gross margin is 84.47%, with operating margin of -7.09%, and net profit margin of -10.36%.
Gross Margin84.47%
Operating Margin-7.09%
Pretax Margin-10.41%
Net Profit Margin-10.36%
EBITDA Margin-6.01%
EBIT Margin-9.45%
Analyst Forecast
The average price target for New Horizon Health Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―